Savient (SVNT) Sees Upside on Renewed Takeover Speculation
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Join SI Premium – FREE
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) is seeing early action on renewed takeover speculation. Shares are up 9%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- Tesla Nears Unveiling of Radical New ‘Flying’ Roadster - The Information
- Vox Royalty agrees to buy two Australian royalties for A$3.4M
Create E-mail Alert Related Categories
RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
